The mitochondrial permeability transition pore (mPTP), a highâconductance channel triggered by a sudden Ca2+ concentration increase, is composed of the F1FOâATPase. Since mPTP opening leads to mitochondrial dysfunction, which is a feature of many diseases, a great pharmacological challenge is to find mPTP modulators. In our study, the effects of two 1,5âdisubstituted 1,2,3âtriazole derivatives, fiveâmembered heterocycles with three nitrogen atoms in the ring and capable of forming secondary interactions with proteins, were investigated. Compounds 3a and 3b were selected among a wide range of structurally related compounds because of their chemical properties and effectiveness in preliminary studies. In swine heart mitochondria, both compounds inhibit Ca2+âactivated F1FOâATPase without affecting FâATPase activity sustained by the natural cofactor Mg2+. The inhibition is mutually exclusive, probably because of their shared enzyme site, and uncompetitive with respect to the ATP substrate, since they only bind to the enzymeâATP complex. Both compounds show the same inhibition constant (KÊči), but compound 3a has a doubled inactivation rate constant compared with compound 3b. Moreover, both compounds desensitize mPTP opening without altering mitochondrial respiration. The results strengthen the link between Ca2+âactivated F1FOâATPase and mPTP and suggest that these inhibitors can be pharmacologically exploited to counteract mPTPârelated diseases.